Clinical Trial to Evaluate ET-01 in Subjects With Lateral Canthal Lines
Active, no longer recruiting
Phase of Trial: Phase II
Latest Information Update: 17 Aug 2018
At a glance
- Drugs Botulinum-Toxin-A (Primary)
- Indications Facial-wrinkles
- Focus Therapeutic Use
- Sponsors Eirion Therapeutics
- 07 Aug 2018 Planned End Date changed from 1 Jul 2018 to 1 Nov 2018.
- 07 Aug 2018 Planned primary completion date changed from 1 Mar 2018 to 1 Aug 2018.
- 07 Aug 2018 Status changed from recruiting to active, no longer recruiting.